|
2024
|
Invention
|
Tri-substituted aryl and heteroaryl derivatives as modulators of pi3-kinase and autophagy pathway... |
|
2023
|
Invention
|
Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof.
The present disclosure rel... |
|
2022
|
Invention
|
Compounds as modulators of tlr2 signaling.
The present disclosure relates to compounds, pharmace... |
|
2021
|
Invention
|
Compounds and compositions as modulators of tlr signaling.
The present disclosure relates to com... |
|
|
Invention
|
Compounds and compositions as modulators of tlr signaling. The present disclosure relates to comp... |
|
|
Invention
|
Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof. The present disclosure rela... |
|
2020
|
Invention
|
Compounds and compositions as modulators of tlr signaling. The present disclosure relates to subs... |
|
2019
|
Invention
|
Method of treating a condition associated with neurodegeneration using inhibitors of oat3.
The p... |
|
|
Invention
|
Method of treating a condition associated with neurodegeneration using inhibitors of oat3. The pr... |
|
|
Invention
|
Morpholine derivates as inhibitors of vps34. The present disclosure relates to thiazole- or diath... |
|
|
Invention
|
Compounds as modulators of tlr2 signaling. The present disclosure relates to compounds, pharmaceu... |
|
2017
|
Invention
|
Lipid-substituted amino 1,2-and 1,3-diol compounds as modulators of tlr2 dimerization. The presen... |
|
2016
|
Invention
|
Bis-heteroaryl derivatives as modulators of protein aggregation. The present invention relates to... |
|
|
G/S
|
Pharmaceutical preparations for the treatment, prognosis or diagnosis of disorders of the nervous... |
|
2015
|
Invention
|
Aminomethyl- and methyloxy-linked tricyclic compounds as inhibitors of protein aggregation. The p... |
|
|
Invention
|
Heteroaryl amides as inhibitors of protein aggregation. The present invention relates to certain ... |
|
2014
|
Invention
|
Compound suitable for the treatment of synucleopathies.
The present invention relates to certain... |
|
2013
|
Invention
|
Aryl- and heteroaryl-substituted benzene derivatives as modulators of pi3-kinase signalling pathw... |
|
|
Invention
|
Aryl-and heteroaryl-substituted benzene derivatives as modulators of pi3-kinase signalling pathwa... |
|
|
Invention
|
Di- and tri-heteroaryl derivatives as inhibitors of protein aggregation. The present invention re... |
|
|
Invention
|
Di-and tri-heteroaryl derivatives as inhibitors of protein aggregation. The present invention rel... |
|
|
Invention
|
Phenyl-urea and phenyl-carbamate derivatives as inhibitors of protein aggregation. The present in... |
|
|
Invention
|
Methods and compounds to be used in the treatment of neurodegenerative diseases. The present inve... |
|
2010
|
Invention
|
Compound suitable for the treatment of synucleopathies. 3 is a substituted or unsubstituted aroma... |
|
|
Invention
|
Compound. The present invention relates to a compound of formula (I): Wherein R1 is a substituted... |
|
|
Invention
|
Compound suitable for the treatment of synucleopathies. The present invention relates to a compou... |
|
2009
|
G/S
|
Research and development services in the field of pharmaceuticals and treatments for neurological... |
